journal of thrombosis and thrombolysis سال:2019 - دوره:48

Fa | Ar | En


journal of thrombosis and thrombolysis
سال:2019 - دوره:48 - شماره:4

a narrative review of red blood cell distribution width as a marker for pulmonary embolism - صفحه:638-647 apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement? - صفحه:619-622 assessing patient preferences for switching from warfarin to direct oral anticoagulants - صفحه:596-602 assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (pdac) using rapid thromboelastography (r-teg) - صفحه:648-652 assessment of the reporting quality of rcts for novel oral anticoagulants in venous thromboembolic disease based on the consort statement - صفحه:542-553 assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy - صفحه:570-579 description of anti-xa monitoring practices during low molecular weight heparin use - صفحه:623-628 first evidence for a pharmacist-led anticoagulant clinic in a medicare part a long term care environment - صفحه:690-693 ibrutinib related bleeding complications in elderly patients with b cell malignancies - صفحه:694-696 interhospital transfer on intravenous thrombolysis in patients with acute ischemic stroke in three chinese municipal stroke centers - صفحه:580-586 intravenous thrombolysis in acute ischemic stroke due to intracranial artery dissection: a single-center case series and a review of literature - صفحه:679-684 lethal concentrations of mercury or lead do not affect coagulation kinetics in human plasma - صفحه:697-698 minoca presenting with stemi: incidence, aetiology and outcome in a contemporaneous cohort - صفحه:533-538 next generation sequencing in bleeding disorders: two novel variants in the f5 gene (valencia-1 and valencia-2) associated with mild factor v deficiency - صفحه:674-678 outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world japanese clinical settings - صفحه:653-660 pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study - صفحه:554-562 pre-procedural abnormal function of von willebrand factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement - صفحه:610-618 prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the platelet inhibition and patient outcomes (plato) trial - صفحه:563-569 prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study - صفحه:603-609 survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: support-af ii study - صفحه:629-637 the need for an adapted initiation nomogram during fiix prothrombin time monitoring of warfarin - صفحه:685-689 thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the command vte registry - صفحه:587-595 ticagrelor after pharmacological thrombolysis in patients with st-segment elevation myocardial infarctions: insight from a trial sequential analysis - صفحه:661-667 use of p2y12 inhibitors among medicaid beneficiaries between 2008 and 2018 - صفحه:539-541 venous thromboembolism 2011–2018 in stockholm: a demographic study - صفحه:668-673